InVivo Therapeutics Holdings Corporation (NVIV) NASDAQ
0.32
-0.1673(-34.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
InVivo Therapeutics Holdings Corporation
Address
One Kendall Square
Cambridge, MA 02139
United States of America (the)
Phone
617 863 5500
Sector
Healthcare
Industry
Biotechnology
Employees
6
First IPO Date
November 15, 2010
Key Executives
| Name | Title | Pay | Year Born |
| Richard Toselli | President, Chief Executive Officer, Chief Medical Officer & Director | 825,204 | 1958 |
| Heather Hamel | Chief Legal Officer & General Counsel | 446,957 | 1990 |
| Richard C. Christopher | Chief Financial Officer & Treasurer | 537,816 | 1970 |
| Joseph Philip Vacanti | Co-Founder | 0 | 1949 |
| Robert S. Langer Jr. | Co-Founder & Member of Scientific Advisory Board | 0 | 1949 |
Description
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
